Ultra Low Dose LNG IUS
Alternative Name: LNG Contraceptive IUS 12 (LCS12)
Description: A low-dose levonorgestrel contraceptive intrauterine system (LCS), LCS12 delivers 12 µg/24h and is effective for 3 years. It is under development by Bayer Healthcare.
Product Details
Duration: 3 years
Regimen:
Dose: 12 microg/24 h
Active Pharmaceutical Ingredient (API):
Status Details
Status Details: - Phase III clinical trial completed in 2015.
- In Nov. 2015, Bayer preregistered the product for contraception in the European Union.
- Phase III clinical trial completed in 2015.
- In Nov. 2015, Bayer preregistered the product for contraception in the European Union.
Additional Information
References: Bayer HealthCare website: http://pharma.bayer.com/
ClinicalTrials.gov Identifier: NCT00528112
Bayer HealthCare website: http://pharma.bayer.com/
ClinicalTrials.gov Identifier: NCT00528112